Satsuma Pharmaceuticals Inc (STSA)
US80405P1075 - Common Stock
Satsuma Pharmaceuticals Inc
NASDAQ:STSA (6/7/2023, 7:00:00 PM)
After market: 1.07 -0.03 (-2.73%)1.1
-0.01 (-0.9%)
Company Profile
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Durham, North Carolina and currently employs 25 full-time employees. The company went IPO on 2019-09-13. The firm is focused on developing a therapeutic product for the acute treatment of migraine. The firm's product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate (DHE), which is designed to self-administered with a pre-filled, single-use, nasal delivery device. STS101 also incorporates an improved 2nd-generation nasal delivery device. STS101 is specifically designed to deliver the clinical advantages of DHE while overcoming its shortcomings.
Company Info
Satsuma Pharmaceuticals Inc
4819 Emperor Boulevard, Suite 340
Durham NORTH CAROLINA 64080
P: 14155050809.0
CEO: John Kollins
Employees: 25
Website: https://www.satsumarx.com/
STSA News
a year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, TESS, NATI, STSA/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
January 2024 PDUFA date expectedIf approved, STS101 would become the only DHE product evaluated in a randomized, placebo-controlled trial (the SUMMIT...
a year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
a year ago - Kahn Swick & Foti, LLCSATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSAa year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HSKA, TESS, NATI, STSA/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
a year ago - Halper Sadeh LLPSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TESS, STSA, CHRA/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
STSA Twits
Here you can normally see the latest stock twits on STSA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
